Facebook
Instagram
Pinterest
Reddit
Tumblr
Twitter
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 131
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files
Center for MINDS: Bruce Damer on Why We Need Psychedelic-Catalysed Innovation
The Psychedelic News Feed: January 26 – Febraury 1, 2026
Q3 2025: Oregon Psilocybin Services Update
Patient Safety After a Death: What Transparency Can and Cannot Do
Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health...
Mindset Pharma to Participate in Upcoming Conferences in December 2022
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December
Gut Feeling: Links Between LSD, Endocannabinoids, and the Microbiome
PT377 – Integrative Medicine: Health, Wellness, and Psychedelics
atai Life Sciences Strengthens Leadership Team with Appointment of Dr. Sahil...
BetterLife Announces Closing of Private Placement
Diamond Therapeutics completes Phase I clinical study of low-dose psilocybin in...
Psychedelic Bulletin #126: Journey’s Mescaline Patent Pledge; Therapeutic Alliance Doesn’t Predict...
COMP360 psilocybin therapy shows potential in open-label study in type II...
1
...
130
131
132
...
307
Page 131 of 307
